Skip to main content
. 2024 Sep 2;14:20380. doi: 10.1038/s41598-024-71733-4

Table 1.

Baseline characteristics of the participants based on the presence of MetS.

Non-MetS MetS P-value
N 330 271
Gender, m/f 244/86 198/73
Age (years) 36.89 ± 13.59 42.76 ± 12.38 0.000
WC (cm) 82.57 ± 9.81 88.42 ± 11.54 0.000
HC (cm) 91.22 ± 8.34 93.33 ± 8.68 0.009
BMI (kg/m2) 23.72 ± 3.63 25.62 ± 3.62 0.000
SBP (mmHg) 119.30 ± 12.48 134.48 ± 14.77 0.000
DBP (mmHg) 77.16 ± 8.12 88.07 ± 8.83 0.000
FBG (mmol/L) 6.11 ± 2.92 8.06 ± 4.17 0.000
TG (mg/dL) 151.94 ± 92.50 225.34 ± 122.98 0.000
TC (mg/dL) 182.16 ± 53.80 223.95 ± 85.21 0.000
HDL-C (mg/dL) 35.00 ± 12.31 31.70 ± 11.76 0.003
LDL-C (mg/dL) 117.72 ± 48.58 151.61 ± 78.60 0.000
XO (U/L) 3.86 ± 2.90 5.34 ± 3.39 0.000
SUA (mg/dL) 6.09 ± 1.92 5.69 ± 1.93 0.014
Hyperuricemia (%) 29.2 25.6 0.327
Diabetes (%) 24.5 53.1 0.000
Hypertension (%) 19.1 64.6 0.000
Physical activity (%)
 Low 20.9 24.2 0.402
 Moderate/adequate 79.1 75.8 0.470
Smoking (%)
 Yes 23.0 18.8 0.208
 No 77.0 81.2 0.247

MetS: Metabolic Syndrome. Values are presented as mean ± SD. P-values for continuous and categorical variables are obtained from independent sample t-test and chi-square test, respectively.